Skip Nav

HIV/AIDS Clinical Trials

Recruiting Status Legend

Studies Seeking Participants

Recruiting
Not yet recruiting
Available for expanded access

Studies Not Seeking Participants

Active, not recruiting
Completed
Terminated
Suspended
Withdrawn
Enrolling by invitation
Temporarily not available for expanded access
No longer available for expanded access
Approved for marketing

Clinical Trial Search Results

53 studies were found about rifampin

Drug Interaction Between Coartem® and Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00620438

Active, not recruiting

The Pharmacokinetics and Safety of IDV/r With NRTIs in HIV/TB Co-infected Patients Receiving Rifampicin

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00411996

Completed

Efavirenz-based Versus Nevirapine-based Antiretroviral Therapy Among HIV-infected Patients Receiving Rifampin

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00483054

Completed

A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.

Condition: Mycobacterium Avium-intracellulare Infection; HIV Infections

NCT ID: NCT00000641

Completed

Comparing Daily vs Intermittent Regimen of ATT in HIV With Pulmonary Tuberculosis

Condition: HIV Infection; Pulmonary TB

NCT ID: NCT00933790

Recruiting

Nevirapine Drug Levels in HIV Positive Patients Also Receiving Rifampicin for Tuberculosis

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00617643

Completed

Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in HIV

Condition: HIV Infection; Tuberculosis

NCT ID: NCT01601626

Recruiting

Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00000636

Completed

Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00000638

Completed

Efficacy and Safety of 2 Raltegravir Doses in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00822315

Completed

Safety, Tolerability, and Blood Levels of Ritonavir-Boosted Atazanavir and Rifampin When Taken Together in HIV Uninfected Adults

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00096850

Completed(En español)

Pharmacokinetics (PK) and Safety of 2 Different Doses of Lopinavir/Ritonavir in in HIV/Tuberculosis (TB) Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy

Condition: HIV Infections; Tuberculosis

NCT ID: NCT01138202

Recruiting

Efficacy Safety Study Comparing 2 Doses of NVP After Initiating Rifampin-containing TB Therapy

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00476853

Completed

Efficacy and Safety of Concomitant Use of Nevirapine and Rifampicin With HIV-TB

Condition: HIV/TB Co-infection

NCT ID: NCT01805258

Completed

Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications

Condition: Opioid Dependency; HIV Infections

NCT ID: NCT00877591

Completed

Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00000950

Completed(En español)

Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146 CARINEMO)

Condition: Tuberculosis; Aids; Hiv Infections

NCT ID: NCT00495326

Completed

A Randomized Trial of Three Regimens to Prevent Tuberculosis in HIV-Infected Patients With Anergy

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00402610

Completed

Immune Activation and Drug Absorption in HIV-Infected Patients

Condition: HIV Infection

NCT ID: NCT01845298

Not yet recruiting

Efavirenz (EFV) in HIV-Infected and HIV/Tuberculosis (TB) Coinfected Children

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00802802

Recruiting(En español)

An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin

Condition: HIV Infection; Tuberculosis

NCT ID: NCT00771498

Recruiting

The Treatment of Tuberculosis in HIV-Infected Patients

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00001033

Completed

A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00000796

Completed

Rifampin and Efavirenz Interactions in Older Children

Condition: HIV; Tuberculosis

NCT ID: NCT01704144

Recruiting

Efficacy of Thrice Weekly Directly Observed Treatment, Short-course (DOTS) in HIV-associated Tuberculosis

Condition: HIV Infections; Acquired Immunodeficiency Syndrome; Tuberculosis

NCT ID: NCT00698334

Completed

Randomized Clinical Trial to Assess the Efficacy and Safety of Concomitant Use of Rifampicin and Efavirenz 600 X 800mg

Condition: Tuberculosis; HIV Infections

NCT ID: NCT00533390

Terminated

Rifampin and Nevirapine Interactions in Young Children

Condition: Tuberculosis; HIV

NCT ID: NCT01699633

Recruiting

Short Course Intermittent Regimens for the Treatment of HIV-Associated Tuberculosis

Condition: Tuberculosis; Human Immunodeficiency Virus Infections

NCT ID: NCT00376012

Active, not recruiting

REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) Treatment

Condition: HIV Infection

NCT ID: NCT01380080

Recruiting

Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium Tuberculosis

Condition: HIV Infections

NCT ID: NCT00402454

Completed

Tuberculosis Prevention for HIV Infected Adults

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00057122

Completed

Pharmacokinetic Study of Super-boosted Lopinavir/Ritonavir Given With Rifampin

Condition: AIDS; Tuberculosis

NCT ID: NCT01700790

Not yet recruiting

Phase 1, Open Label, Two Arm, Fixed Sequence Study to Evaluate the Effect of Rifampin and Rifabutin on GSK1349572 Pharmacokinetics in Healthy Male and Female Volunteers

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01231542

Completed

Pharmacokinetics of Emtricitabine/Tenofovir/Efavirenz in HIV-infected Patients With Tuberculosis

Condition: Tuberculosis; HIV Infections

NCT ID: NCT00474435

Recruiting

Pharmacokinetics of Anti-TB Drugs in HIV/TB Co-infected Children in Ghana

Condition: Tuberculosis; HIV

NCT ID: NCT01687504

Recruiting

The Effect of Intermittent Rifampicin on Raltegravir

Condition: HIV; Tuberculosis

NCT ID: NCT01424826

Active, not recruiting

Optimal Time to Initiate Antiretroviral Therapy in HIV & TB Coinfected Adults Being Treated for Tuberculosis

Condition: Acquired Immunodeficiency Syndrome; Tuberculosis

NCT ID: NCT01315301

Recruiting

Evaluating the Safety, Tolerance, Drug Interactions, and Effective Dosing of a Raltegravir-Containing Antiretroviral Therapy (ART) Regimen in ART-Naive Children Infected With HIV and TB

Condition: HIV Infections; Tuberculosis

NCT ID: NCT01751568

Not yet recruiting(En español)

A Study to Determine the Best Dose of Antivirals in Patients With Both TB and HIV

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00523458

Terminated

Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study)

Condition: Tuberculosis; HIV

NCT ID: NCT01637558

Recruiting

Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in Pulmonary Tuberculosis Suspects

Condition: Tuberculosis

NCT ID: NCT01587469

Recruiting

Evaluation of the Pharmacokinetics of Antituberculosis Drugs and Tuberculosis Treatment Outcomes

Condition: AIDS With Tuberculosis

NCT ID: NCT01782950

Not yet recruiting

Durability of Nevirapine-Based Antiretroviral Regimen

Condition: HIV Infections

NCT ID: NCT00703898

Completed

EARNEST Rifabutin Pharmacokinetics (PK) Substudy

Condition: HIV; Tuberculosis

NCT ID: NCT01663168

Recruiting

Tuberculosis Treatment Shortening Trial

Condition: Tuberculosis

NCT ID: NCT00130247

Completed

Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in Vietnam

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00651066

Active, not recruiting

Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in South Africa

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00640887

Completed

Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy

Condition: HIV Infections

NCT ID: NCT00042289

Recruiting(En español)

Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis

Condition: HIV Infection; Tuberculosis

NCT ID: NCT00108862

Completed(En español)

Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia.

Condition: Mycobacterium Avium-Intracellulare Infection; HIV Infections

NCT ID: NCT00002192

Completed

Safety and Efficacy of Oral Immunomodulator in Tuberculosis (TB) and TB/HIV Patients

Condition: Tuberculosis

NCT ID: NCT01222338

Completed

Interaction Study to Assess the Pharmacokinetic Interaction of Oral Administration of Rifapentine on ATRIPLA™ in HIV Patients

Condition: Tuberculosis

NCT ID: NCT01690403

Recruiting

TBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl Rifapentine

Condition: Tuberculosis

NCT ID: NCT00023387

Completed